PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
8 hedge funds and large institutions have $5.07M invested in PAVmed Inc. Series Z Warrant in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
161% more capital invested
Capital invested by funds: $1.94M → $5.07M (+$3.13M)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$1.82M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$191K |
| 3 |
LCS
Levin Capital Strategies
New York
|
+$139K |
| 4 |
VF
Virtu Financial
New York
|
+$118K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$5.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$374K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14.9K |
| 4 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$3K |
PAVMZ Hedge Fund Activity: Q3 2021 in Review
8 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2021, worth a combined $5.07M — up 161% from $1.94M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PAVMZ and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Warberg Asset Management, adding an estimated $1.82M. The largest seller was Ionic Capital Management, exiting entirely with an estimated $374K sold.
- 8 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2021, down from 9 in Q2 2021.
- Funds reported $5.07M of PAVmed Inc. Series Z Warrant stock for Q3 2021, up 161% quarter-over-quarter.
- 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2021 and 3 closed out, a net change of -1 holder.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2021 was Warberg Asset Management, an estimated $1.82M added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2021 was Ionic Capital Management, an estimated $374K sold.
Based on aggregated 13F filings for Q3 2021.